First-line serplulimab in metastatic colorectal cancer: Phase 2 results of a randomized, double-blind, phase 2/3 trial

作者：Zixian Wang, Junjie Peng, Xinjun Liang, Ying Cheng, Yanhong Deng, Kehe Chen, Mingjun Zhang, Jingdong Zhang, Wei Wang, Bangwei Cao, Yongdong Jin, Meili Sun, Yuan Lin, Suxia Luo, Zhen Li, Yang Liu, Ying Ke, Haoyu Yu, Jing Li, Qingyu Wang, Junwu Zhu, Feng Wang, Rui‐Hua Xu · 发表于：Med · 年份：2024 · DOI：10.1016/j.medj.2024.05.009 · 被引用次数：17 · 研究领域：Genetic factors in colorectal cancer、Colorectal Cancer Treatments and Studies、Cancer Immunotherapy and Biomarkers